Saturday, December 14, 2024

Tag: Kazia Therapeutics

Kazia Therapeutics: Raises $4.5m and launches SPP

Kazia Therapeutics Raises $4.5m and launches SPPKazia Therapeutics (KZA) launches $4.5 million via a placement to drive its...

Kazia Therapeutics: Partners with DFCI to treat rare lymphoma

Cancer treatment specialist Kazia Therapeutics (KZA) is teaming up with the U.S. Dana-Farber Cancer Institute (DFCI) to treat...

Kazia Therapeutics: Closes $1.8M share purchase plan

Kazia Therapeutics: Closes $1.8M share purchase planBiotech company Kazia Therapeutics (KZA) has closed its $1.8M share purchase plan ...

Kazia Therapeutics: Completes recruitment for ongoing paxalisib phase 2 study

Kazia Therapeutics: Completes recruitment for ongoing paxalisib phase 2 studyKazia Therapeutics has also completed the recruitment stage for...